Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Lonza division Lonza Biotec (Visp, Switzerland) will manufacture for CCH PEGylated antibody fragment-based compounds. CCH's
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury